Palliative RT Flashcards

1
Q

what is the issue with size of trt volume

A

GTV, CTV, PTV not usually defined
adequate margins, organ movement, set up margins
areas defined by pt need

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the issue of the complexity of trt

A

pragmatic approach
imaging areas which need to be traa was ted
osteolytic + sclerotic lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

issue with accessory set up

A

pt comfortable
simple
immobilisation
appropriate
linac or kv equipment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

issues with pt care

A

analgesia
special care required
care would need to be site related
IP/OP
transport
family support
end of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is given alongside brain met patients

A

corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the survival for corticosteroids alone

A

2 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

brain met RT is given to what lesions

A

single or multiple deposits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how long does WBRT lengthen life for

A

6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

is there a difference between WBRT and SRS

A

no survival difference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is SRS for

A

single or limited met deposits
improved local control with focal therapy - high dose with rapid fall off to normal tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is WBRT less likely to cause

A

neurological death (brain has lost its function)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what machines offer SRS

A

gamma knife
cyber knife
gantry based linac with micro MLCs
PBT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the SRS dose

A

16.2-25 Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

WBRT dose

A

30-40Gy in 15-20# in 3-4 wks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what treatment is given got aggressive disease

A

surgery, post op RT, chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what high grade gliomas are treated

A

anaplastic astrocytoma and GBM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the survival for surgery alone with brain mets

A

6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is surgery and post op RT survival for AA and GBM

A

AA = 36 months
GBM = 9-10 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the survival for surgery, post op and chemo for AA and GBM

A

15% relative reduction in risk of death
AA = 37% 2 year survival
GBM = 9-13% 2 year survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the cranial SE

A

vasculature
- endothelial cell death
- blood vessel wall thickening
- vessel occulsion
glial cells useful
- cerebral atrophy
- cognitive defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

WBRT TV

A

WB, olfactory groove and middle cranial fossa
inf border = supra orbital ridge and EAM
covers scalp 5mm margin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the technique for WBRT

A

POP
isocentric fixed FSD
6MV

23
Q

what is the dose for WBRT

A

30Gy in 10
30-40Gy in 15-20
20Gy in 5
12Gy in 2 over a week

24
Q

what would a pt need that has multiple bone mets

A

a field match

25
Q

what is the TV of a bone met based on

A

pt symptoms

26
Q

what is the role of RT for bone mets

A

control pain
prevent pathological fractures

27
Q

what should be treated/avoided in RT for bone mets

A

whole bone/structure should be treated (vertebrae, hemipelvis) intervertebral discs)
channel of normal tissue (preserve lymphatic drainage)
joint spaces should be avoided

28
Q

what happens to bone due to osteolytic lesions

A

they replace normal bone with a blast portion showing a lower attenuation with the normal cancellous bone, this comprises lesions with fatty liquid and solid soft tissue components

29
Q

what is the characteristics of a bone met

A

matrix mineralisation, osteoid, chondroid, fibrous
septations and trabeculations
moth eaten
margin types: sclerotic, well
defined, poorly defined or indistinct
described as wide or narrow zone of transition
cortical involvement: cortical expansion, cortical destruction
periosteal reaction: benign or aggressive

30
Q

what is the RT for local bone pain

A

single direct or POP
300kv @ 3cm depth
SC depth to body is 5-8cm
8Gy in 1
however alternatives are 20Gy in 5 or 30Gy in 10

31
Q

what is the post op RT for bone mets

A

for pt with longer prognosis
8Gy in 1, 20Gy in 5 or 30Gy in 10
lymphatic channel margin
TV is not clear either whole bone or prosthesis and a margin for micro mets (3cm)

32
Q

what is the sup borders for hemibody irradiation

A

top of scalp - umbilicus or
chin (extended) - umbilicus

33
Q

what is the inf borders for hemi body irradiation

A

umbilicus - soles of feet

34
Q

RT field hemibody iradiation

A

field: 4cm or extended FSD
field matching due to divergent beams

35
Q

doses for hemibody

A

8Gy in 1
20Gy in 5
30Gy in 10

36
Q

what is the gap between the different fields for hemibody

37
Q

what is the max lung dose for hemibody

38
Q

what are the considerations for hemibody

A

QoL and co-morbidities
travel
RT outcome
single exposure might be preferred
possibility of path fracture

39
Q

what is the aetiology for bladder cancer - palliative

A

70+
smoking
poor health
co-morbidities: muscle invasive bladder cancer

40
Q

what is the trt for bladder cancer

A

surgery or chemo
if not suitable for chemo then RT

41
Q

indications for RT for bladder cancer

A

haematuria: heavy bleeding, clots
urinary symptoms
local pain

42
Q

what is the RT volume for bladder cancer

A

empty bladder
minimal volume
CT sim
location

43
Q

what is the potential issues for bladder cancer

A

failure of treatment (30-40%)
fistuala (uncommon)
- vesico-vaginal
- vesico - colic
- vesico - rectal

44
Q

what are the doses which can be given for bladder cancer if they have 6 months or more.

A

21Gy in 3# over 5 days
35Gy in 10# over 12 days

45
Q

what are the doses given for pall bladder cancer pts with poor prognosis

A

17Gy in 2# over 3 days
14Gy in 4# once per month
8Gy in 1#

46
Q

what is the percentage reduction for haematuria in fractionated and conventional regimes

A

fractionated: 60-65% reduction
conventional: 70%

47
Q

what does the primary for lung mets tend to be

A

breast
colon
prostate
lung

48
Q

indications for RT for lung Mets

A

symptomatic with advanced disease
80% response with haemopytsis
60% response with chest pain
30% response with dyspnoea

49
Q

what is the immobilisation for lung Mets

A

non
supine
arms by side

50
Q

what is the volume for lung Mets

A

primary + nodes + 2cm margin

51
Q

what is the field for lung Mets

A

non complex POP (A+P)
isocentric/fixed FSD
complex iso technique = radical approach, palliative intent
verification

52
Q

what are the doses for lung Mets

A

6MV
39Gy in 13# in 2.5 weeks
16Gy in 2# once a week
10Gy in 1 #

53
Q

what is the acute toxicity for cranial RT

A

cerebral oedema
transient worsening of pre treatment symptoms
required corticosteroids (dexamethasone 4mg)
radiation dermatitis and permanent alopecia
nausea and vomiting (antiemetics)